NCT06169085View on ClinicalTrials.gov

Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

September 20, 2023

Study Completion Date

October 11, 2023

Conditions
Elder
Interventions
DRUG

Leritrelvir

Oral

Trial Locations (1)

Unknown

Wuhan Jinyintan Hospital, Wuhan

All Listed Sponsors
lead

Guangdong Raynovent Biotech Co., Ltd

INDUSTRY

NCT06169085 - Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants | Biotech Hunter | Biotech Hunter